• Citius Pharmaceuticals updates pipeline as investors track CTXR stock AD HOC NEWS Tue, 07 Jul 2026 19:42:24 GMT
• citius pharmaceuticals inc (nasdaq:ctxr) is a biotech runner: here's why Insider Financial Thu, 02 Jul 2026 09:07:45 GMT
• CTXR Q4 2025 Earnings: Wider-Than-Expected Losses as Drug Development Continues - Earnings Forecast Report dars.gov.et Sun, 28 Jun 2026 07:00:00 GMT
• price to earnings forward of citius pharmaceuticals, inc. – nasdaq:ctxr TradingView Fri, 26 Jun 2026 16:55:42 GMT
• enterprise value to ebit forward of citius pharmaceuticals, inc. – nasdaq:ctxr TradingView Fri, 26 Jun 2026 13:02:46 GMT
• Price to sales forward of Citius Pharmaceuticals, Inc. – BOATS:CTXR TradingView Fri, 26 Jun 2026 09:30:41 GMT
• enterprise value to revenue forward of citius pharmaceuticals, inc. – boats:ctxr TradingView Fri, 26 Jun 2026 08:08:22 GMT
• Citius Pharmaceuticals updates I/ ONTAK launch progress, shares trade on Nasdaq AD HOC NEWS Thu, 25 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) valuation: pe, pb & fair value analysis TradingKey Thu, 25 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) valuation: pe, pb & fair value analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) price target increased by 20.00% to 6.12 MSN Mon, 22 Jun 2026 09:17:23 GMT
• citius pharmaceuticals inc (ctxr) technical analysis: support, resistance, indicators & moving averages TradingKey Fri, 19 Jun 2026 04:47:12 GMT
• Citius Pharmaceuticals Inc (CTXR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 10:03:15 GMT
• citius pharmaceuticals inc (ctxr) institutional confidence TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• citius pharmaceuticals inc (ctxr) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 01:17:03 GMT
• citius pharmaceuticals inc (ctxr) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 04:26:38 GMT
• citius pharmaceuticals inc (ctxr) institutional confidence TradingKey Wed, 17 Jun 2026 04:26:04 GMT
• citius pharmaceuticals inc (ctxr) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 03:59:00 GMT
• Citius Pharmaceuticals Inc (CTXR) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Wed, 17 Jun 2026 03:56:58 GMT
• citius pharmaceuticals inc (ctxr) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 03:55:15 GMT
• citius oncology (ctor) stake updated by majority holder citius pharma Stock Titan Thu, 04 Jun 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) 10k form and latest sec filings 2026 MarketBeat Tue, 02 Jun 2026 07:00:00 GMT
• Citius Oncology presents study data on LYMPHIR combination Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• Citius Oncology (NASDAQ: CTOR) highlights Phase 1 LYMPHIR plus pembrolizumab results Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• citius oncology (nasdaq: ctxr) shares early phase 1 lymphir cancer data Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• citius oncology highlights phase 1 data in an investigator-initiated study of lymphir® (denileukin diftitox-cxdl) in combination w... BioSpace Mon, 01 Jun 2026 07:00:00 GMT
• citius oncology (ctor) registers 6.8m warrant shares; highlights phase 1 lymphir data Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Breakeven On The Horizon For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) simplywall.st Thu, 28 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) edges higher as trading volume remains subdued - etf outflow streak dars.gov.et Wed, 27 May 2026 07:00:00 GMT
• Citius Oncology Announces Presentation of LYMPHIR® Phase 1 Combination Study Data at the 2026 American Society of Clinical Oncolog... PR Newswire Tue, 26 May 2026 07:00:00 GMT
• lymphir and pembrolizumab phase 1 combination data featured by citius pharmaceuticals at asco2026 Traders Union Tue, 26 May 2026 07:00:00 GMT
• Citius Pharmaceuticals Draws Analyst Coverage as LYMPHIR Commercial Launch Gains Momentum dars.gov.et Mon, 25 May 2026 07:00:00 GMT
• Is Citius Pharmaceuticals, Inc. (CTXR) among the Best Rated Penny Stocks to Buy According to Wall Street Analysts? Yahoo Finance Sun, 24 May 2026 07:00:00 GMT
• citius pharmaceuticals (nasdaq: ctxr) registers 5.43m resale shares from warrants Stock Titan Fri, 22 May 2026 07:00:00 GMT
• 5 best rated penny stocks to buy according to wall street analysts Insider Monkey Fri, 22 May 2026 02:23:56 GMT
• h.c. wainwright maintains citius pharmaceuticals(ctxr.us) with buy rating, maintains target price $4 富途牛牛 Wed, 20 May 2026 11:00:51 GMT
• h.c. wainwright maintains citius pharmaceuticals(ctxr.us) with buy rating, maintains target price $4 Moomoo Tue, 19 May 2026 19:26:05 GMT
• citius pharmaceuticals reports increased losses in q2 fy 2026 Intellectia AI Tue, 19 May 2026 18:43:36 GMT
• citius pharmaceuticals price target announced at $4.00/share by hc wainwright & co. Moomoo Tue, 19 May 2026 12:27:24 GMT
• h.c. wainwright initiates citius pharmaceuticals(ctxr.us) with buy rating, announces target price $4 Moomoo Tue, 19 May 2026 07:00:00 GMT
• citius oncology (nasdaq: ctor) majority approves warrant and conversion issuances Stock Titan Tue, 19 May 2026 07:00:00 GMT
• ctxr assumes buy rating by hc wainwright & co. -- price target a GuruFocus Tue, 19 May 2026 00:51:57 GMT
• citius pharmaceuticals assumed with a buy at h.c. wainwright TipRanks Mon, 18 May 2026 13:45:05 GMT
• 12 health care stocks moving in monday's pre-market session - aim immunotech (amex:aim), artelo bioscienc Benzinga Mon, 18 May 2026 07:00:00 GMT
• ctxr assumes buy rating by hc wainwright & co. -- price target a GuruFocus Mon, 18 May 2026 07:00:00 GMT
• citius pharmaceuticals price target announced at $4.00/share by hc wainwright & co. Moomoo Mon, 18 May 2026 07:00:00 GMT
• citius pharmaceuticals stock (us1729001026): focus on cancer and anti-infective pipeline after recen AD HOC NEWS Sun, 17 May 2026 07:00:00 GMT
• citius pharmaceuticals q2 2026 earnings: revenue misses $1.7 million technotrenz.com Sat, 16 May 2026 07:00:00 GMT
• is citius pharmaceuticals (ctxr) undervalued after q2 fy2026 upd GuruFocus Sat, 16 May 2026 04:37:46 GMT
• citius pharmaceuticals (ctxr) price target increased by 20.00% to 6.12 MSN Sat, 16 May 2026 02:38:56 GMT
• citius pharmaceuticals reports $5.6m h1 revenue from lymphir; q2 net loss $21.2m TradingView Fri, 15 May 2026 20:53:01 GMT
• citius pharmaceuticals, inc. 3q fy2026: revenue $1.67m, eps $(0.95) — 10-q summary TradingView Fri, 15 May 2026 20:38:28 GMT
• citius pharmaceuticals announces $2 million registered direct offering of common stock Quantisnow Fri, 15 May 2026 19:48:20 GMT
• Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PR Newswire Fri, 15 May 2026 07:00:00 GMT
• Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update PR Newswire Fri, 15 May 2026 07:00:00 GMT
• CTXR: LYMPHIR launch spurred revenue growth, but losses rose sharply due to a major contract termination TradingView Fri, 15 May 2026 07:00:00 GMT
• citius pharmaceuticals q2 revenue rises on lymphir launch TradingView Fri, 15 May 2026 07:00:00 GMT
• lymphir cancer drug at 83% of target accounts, coverage near 100% Stock Titan Fri, 15 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) logs $5.6m lymphir sales, deeper losses in q2 2026 Stock Titan Fri, 15 May 2026 07:00:00 GMT
• is citius pharmaceuticals (ctxr) undervalued after q2 fy2026 upd GuruFocus Fri, 15 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) starts lymphir sales but faces heavy loss and going concern risk Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ctxr financials: income statement, balance sheet & cash flow Stock Titan Fri, 15 May 2026 07:00:00 GMT
• citius oncology (nasdaq: ctor) flags going concern, adds $25.0 million loan Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ctxr: $5.6m in lymphir revenue, 80% gross margin, $21.2m q2 net loss, $41.5m new financing TradingView Fri, 15 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) 10k form and latest sec filings 2026 MarketBeat Fri, 15 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) price target increased by 20.00% to 6.12 MSN Thu, 14 May 2026 11:48:44 GMT
• ctxr stock chart | citius pharmaceuticals inc (nasdaq:ctxr) ChartMill Thu, 14 May 2026 07:00:00 GMT
• number of shareholders of citius pharmaceuticals inc – gettex:47n0 TradingView Sun, 10 May 2026 22:34:54 GMT
• citius pharmaceuticals announces third amendment to promissory note with citius oncology – sec filing details Minichart Sat, 09 May 2026 07:00:00 GMT
• citius pharmaceuticals (ctxr) adds $0.90 share conversion to $3.8m note Stock Titan Fri, 08 May 2026 07:00:00 GMT
• citius pharmaceuticals amends promissory note to enhance flexibility TipRanks Fri, 08 May 2026 07:00:00 GMT
• ctxr stock price, quote & chart | citius pharmaceuticals inc (nasdaq:ctxr) ChartMill Fri, 08 May 2026 07:00:00 GMT
• ctxr | citius pharmaceuticals inc. common insider trading Quiver Quantitative Thu, 07 May 2026 22:37:01 GMT
• Citius Oncology raises $36.5m for Lymphir commercialisation Pharmaceutical Technology Wed, 06 May 2026 07:00:00 GMT
• citius raises $36.5m for lymphir commercialisation Pharmaceutical Technology Wed, 06 May 2026 07:00:00 GMT
• citius pharmaceuticals subsidiary raises up to 36.5 million dollars for lymphir commercialization Traders Union Wed, 06 May 2026 07:00:00 GMT
• citius oncology, inc. secures up to $36.5 million in debt and equity capital to accelerate lymphir® commercialization PR Newswire Wed, 06 May 2026 00:00:00 GMT
• Citius Oncology, Inc. Secures Up to $36.5 Million in Debt and Equity Capital to Accelerate LYMPHIR® Commercialization PR Newswire Tue, 05 May 2026 07:00:00 GMT
• citius oncology (nasdaq: ctor) registers 6.82m warrant shares, updates lymphir trials and launch Stock Titan Tue, 05 May 2026 07:00:00 GMT
• citius gets $36.5m to back lymphir, its ctcl therapy launch Stock Titan Tue, 05 May 2026 07:00:00 GMT
• citius pharmaceuticals announces closing of $3 million registered direct offering Quantisnow Fri, 01 May 2026 17:31:35 GMT
• ctxr stock chart | citius pharmaceuticals inc (nasdaq:ctxr) ChartMill Fri, 01 May 2026 07:00:00 GMT
• ctxr stock price, quote & chart | citius pharmaceuticals inc (nasdaq:ctxr) ChartMill Fri, 01 May 2026 07:00:00 GMT
• ctxr price today: citius pharmaceuticals inc. stock price, quote & chart | mexc MEXC Exchange Thu, 30 Apr 2026 12:37:24 GMT
• Citius Oncology sees first international shipment of LYMPHIR to Europe ROI-NJ Thu, 30 Apr 2026 07:00:00 GMT
• citius oncology announces initial shipment of lymphir to europe TipRanks Thu, 30 Apr 2026 00:48:47 GMT
• citius oncology shares climb following expansion of lymphir distribution network MSN Wed, 29 Apr 2026 18:20:25 GMT
• first lymphir cancer-drug shipment reaches europe via named-patient access Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• citius oncology ships first international order of lymphir™ to europe PR Newswire Wed, 29 Apr 2026 07:00:00 GMT
• first european lymphir shipment expands citius oncology (ctor) patient access Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• citius pharmaceuticals expands lymphir global reach with initial european shipment Traders Union Wed, 29 Apr 2026 07:00:00 GMT
• citius pharmaceuticals (nasdaq: ctxr) unit sends first lymphir shipment to europe Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• citius oncology announces initial shipment of lymphir to europe TipRanks Wed, 29 Apr 2026 07:00:00 GMT
• citius pharmaceuticals announces closing of registered direct offering of $5 million priced at-the-market under nasdaq rules marketscreener.com Mon, 27 Apr 2026 11:03:17 GMT
• citius pharmaceuticals raises $5 million in securities offering The Globe and Mail Sat, 25 Apr 2026 21:58:00 GMT
• citius pharmaceuticals raises $5m in registered direct offering by investing.com Investing.com Australia Sat, 25 Apr 2026 07:43:34 GMT
• citius pharmaceuticals closes $5m stock offering by investing.com Investing.com Australia Sat, 25 Apr 2026 07:12:19 GMT
• citius pharmaceuticals announces $5 million registered direct offering to support lymphir launch and product development Minichart Sat, 25 Apr 2026 07:00:00 GMT
• citius raises $5m to back lymphir launch, payments and pipeline work Stock Titan Fri, 24 Apr 2026 20:30:00 GMT
• citius pharmaceuticals announces registered direct offering of $15.8 million MSN Fri, 24 Apr 2026 08:02:57 GMT
• Citius Pharmaceuticals Announces Closing of Registered Direct Offering of $5 Million Priced At-The-Market Under Nasdaq Rules PR Newswire Fri, 24 Apr 2026 07:00:00 GMT
• citius pharmaceuticals secures $5m through equity offering Yahoo Finance Fri, 24 Apr 2026 07:00:00 GMT
• citius pharmaceuticals raises $5m in registered direct offering Investing.com Fri, 24 Apr 2026 07:00:00 GMT
• citius pharmaceuticals announces a registered direct offering of $5 million priced at-the-market under nasdaq rules PR Newswire Fri, 24 Apr 2026 07:00:00 GMT
• 12 health care stocks moving in friday's pre-market session Benzinga Fri, 24 Apr 2026 07:00:00 GMT
Citius Pharmaceuticals, Inc(NASDAQ:CTXR) 
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solut...
Website: http://www.citiuspharma.com
Full Time Employees: 10
Sector: Healthcare
Industry: Biotechnology